Syra Health announces preliminary results on Syrenity

Syra Health (SYRA) announced positive preliminary results from the clinical research study being conducted by Indiana University of its flagship mental health product, Syrenity. A randomized clinical research study to test the efficacy of the Syrenity app is being led by Dr. Lorenzo-Luaces, principal investigator and associate department chair of Psychological and Brain Sciences at IU. The IRB-approved study enrolled approximately 135 people who expressed symptoms of moderate or more severe depression. Of the 135 people, 63 were provided access to Syrenity versus 72 people without access. The preliminary analysis of the six-week study suggested trends toward reductions in depression symptoms among Syrenity users compared to those without access to the app. Preliminary trends in overall well-being were also observed, alongside indications of increased cognitive reappraisal-or the ability to mentally reframe experiences to avoid negative emotions. There were also signs of improvement in emotion suppression, an unhealthy coping strategy where a person hides their feelings to try and make themselves feel better.